Bivalirudin Is a Dual Inhibitor of Thrombin and Collagen-Dependent Platelet Activation in Patients Undergoing Percutaneous Coronary Intervention, Circulation: Cardiovascular Interventions, vol.4, issue.2, pp.171-179, 2011. ,
DOI : 10.1161/CIRCINTERVENTIONS.110.959098
Platelet function and coagulation in patients with STEMI and peri-interventional clopidogrel plus heparin vs. prasugrel plus bivalirudin therapy (BRAVE 4 substudy), Thrombosis Research, vol.137, pp.72-78, 2016. ,
DOI : 10.1016/j.thromres.2015.11.016
Bivalirudin during Primary PCI in Acute Myocardial Infarction, New England Journal of Medicine, vol.358, issue.21, pp.2218-2230, 2008. ,
DOI : 10.1056/NEJMoa0708191
URL : http://researchonline.lshtm.ac.uk/7561/1/nejmoa0708191.pdf
Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes, MATRIX Investigators, bivalirudin or unfractionated heparin in acute coronary syndromes, pp.997-1009, 2015. ,
DOI : 10.1056/NEJMoa1507854
URL : https://boris.unibe.ch/71500/1/Valgimigli%20NEnglJMed%202015.pdf
Bivalirudin vs Heparin With or Without Tirofiban During Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction, JAMA, vol.313, issue.13, pp.1336-1346, 2015. ,
DOI : 10.1001/jama.2015.2323
Composition of Coronary Thrombus in Acute Myocardial Infarction, Journal of the American College of Cardiology, vol.57, issue.12, pp.1359-1367, 2011. ,
DOI : 10.1016/j.jacc.2010.09.077
Thrombin generation in acute coronary syndrome and stable coronary artery disease: dependence on plasma factor composition, Journal of Thrombosis and Haemostasis, vol.5, issue.1, pp.104-110, 2008. ,
DOI : 10.1161/01.ATV.15.9.1269
Comparison of Prasugrel and Ticagrelor Loading Doses in ST-Segment Elevation Myocardial Infarction Patients, Journal of the American College of Cardiology, vol.61, issue.15, pp.1601-1606, 2013. ,
DOI : 10.1016/j.jacc.2013.01.024
Onset of optimal P2Y12-ADP receptor blockade after ticagrelor and prasugrel intake in Non-ST elevation acute coronary syndrome, Thromb Haemost, vol.114, pp.702-707, 2015. ,
Consensus and Update on the Definition of On-Treatment Platelet Reactivity to Adenosine Diphosphate Associated With Ischemia and Bleeding, Journal of the American College of Cardiology, vol.62, issue.24, pp.2261-2273, 2013. ,
DOI : 10.1016/j.jacc.2013.07.101
Effect of Short Procedural Duration With Bivalirudin on Increased Risk of Acute Stent Thrombosis in Patients With STEMI, JAMA Cardiology, vol.2, issue.6, 2017. ,
DOI : 10.1001/jamacardio.2016.5669
European society of cardiology working group on thrombosis task force on anticoagulants in heart disease, general mechanisms of coagulation and targets of anticoagulants (Section I) Position paper of the ESC working group on thrombosis?task force on anticoagulants in heart disease, Thromb Haemost, vol.109, pp.569-579, 2013. ,
Greater inhibitory effects of bivalirudin compared with unfractionated heparin plus eptifibatide on thrombin-induced platelet activation, Coron Artery Dis, vol.17, pp.71-476, 2006. ,
Parenteral Anticoagulants, Chest, vol.141, issue.2, pp.24-43, 2012. ,
DOI : 10.1378/chest.11-2291
URL : http://europepmc.org/articles/pmc3278070?pdf=render
Potential mechanism of acute stent thrombosis with bivalirudin following percutaneous coronary intervention in acute coronary syndromes, Int J Cardiol, vol.220, pp.496-500, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01460483
Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Intervention<SUBTITLE>REPLACE-2 Randomized Trial</SUBTITLE>, JAMA, vol.289, issue.7, pp.853-863, 2003. ,
DOI : 10.1001/jama.289.7.853
URL : http://jama.jamanetwork.com/data/journals/jama/4868/joc22311.pdf
Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial), The American Journal of Cardiology, vol.93, issue.9, pp.1092-1096, 2004. ,
DOI : 10.1016/j.amjcard.2004.01.033
Comparison of bivalirudin, enoxaparin, and unfractionated heparin in preventing cardiac catheter thrombosis. Results of an in-vitro study, Thromb Haemost, vol.100, pp.693-698, 2008. ,
Correlation between Activated Clotting Time and Activated Partial Thromboplastin Times, Annals of Pharmacotherapy, vol.19, issue.1 ,
DOI : 10.1093/ajcp/108.6.662
Evaluation of the activated clotting time and activated partial thromboplastin time for the monitoring of heparin in adult extracorporeal membrane oxygenation patients, Perfusion, vol.96, issue.5, pp.456-461, 2014. ,
DOI : 10.1111/j.1423-0410.2008.01110.x
Pharmacokinetics and Pharmacodynamics of Oral Heparin Solid Dosage Form in Healthy Human Subjects, The Journal of Clinical Pharmacology, vol.47, issue.12, pp.1508-1520, 2007. ,
DOI : 10.1177/0091270007307242
Summary, Thrombosis and Haemostasis, vol.98, issue.07, pp.234-242, 2007. ,
DOI : 10.1160/TH06-10-0607